Versant Venture Management, LLC
CIK
1560009
Location
San Francisco, CA
Portfolio Value
Small
$161,394,736
Diversification
Highly concentrated
Filing Date
Global Rank
#7,154
/ 8,794
▼ 401
· as of Jun 2026
Top Industry
Biotechnology
100.0%
Period ended 3 months ago
Filed Aug 12, 2026 · 54d
26 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
8 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
47.7%
+10.4 pts
Top 5
94.7%
+0.1 pts
Top 10
100.0%
0.0 pts
HHI
2,945
Highly concentrated+587
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $161,394,736 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | −534,037 | 991,783 | $22,037,418 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
8 tracked positions ·
$161,394,736 total
· filing declares
8 positions · $162,612,689
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Held | 3,180,780 | $76,974,876 | 47.69% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Held | 12,166,109 | $29,806,967 | 18.47% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Reduced | 991,783 | $22,037,418 | 13.65% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Held | 2,656,888 | $15,091,123 | 9.35% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 542,628 | $8,893,672 | 5.51% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 148,831 | $8,117,242 | 5.03% | |
| TPST |
Tempest Therapeutics, Inc.
Healthcare
|
Held | 269,772 | $299,446 | 0.19% | |
| SKYE |
Skye Bioscience, Inc.
Healthcare
|
Held | 2,007,704 | $173,992 | 0.11% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.